Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant.
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma.
Patterns of common illness and injury of readymade garment workers and a review of safety practices in Bangladesh.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma. Leukemia. 2025 Sep; 39(9):2285-2288.
View in:
PubMed
authors with profiles
Michael Drazer
Jennifer Cooperrider
Caner Saygin
Andrzej Jakubowiak
Benjamin Derman